WebNews
NewsWeb
amoxicillin " Latest Stories " Pain News Network
6+ day, 19+ hour ago (483+ words) Antibiotics are not an effective treatment for chronic lower back pain caused by bulging herniated discs, according to a small new study by researchers in Australia. That may sound like a "Well, duhhh" finding, but some patients with back pain…...
Amneal Pharmaceuticals Inc (AMRX) Q4 2025 Earnings Call Highlights: Strong Financial Growth and. ..
3+ mon, 2+ hour ago (503+ words) Revenue Growth 2025: 8% increase to $3 billion. Adjusted EBITDA Growth 2025: 10% increase to $688 million. Adjusted EPS Growth 2025: 43% increase to $0. 83. Q4 Revenue: 11% increase to $814 million. Q4 Adjusted EBITDA: 13% increase to $175 million. Q4 Adjusted EPS: 75% increase to $0. 21. Operating Cash Flow 2025: $340 million. Net Leverage 2025: Reduced to 3. 5 times. 2026 Revenue Guidance:…...
Lakewood-Amedex advances Nu-3 antimicrobial gel. .. | Pluang " Crypto, Stocks, Gold & Funds
1+ week, 2+ day ago (252+ words) Lakewood-Amedex Biotherapeutics announced positive progress for Nu-3, a topical antimicrobial gel targeting mildly infected diabetic foot ulcers (i DFU). The company has completed key formulation and manufacturing steps under c GMP guidelines, ensuring drug stability and effectiveness for clinical use....
Amneal Launches Bimatoprost Ophthalmic Solution, 0. 01%
1+ mon, 2+ week ago (222+ words) Bimatoprost ophthalmic solution 0. 01% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Amneal Launches Bimatoprost Ophthalmic Solution, 0. 01% BRIDGEWATER, N. J. , April 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Amneal" or the Company") today…...
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin | | caledonianrecord. com
6+ day, 5+ hour ago (351+ words) Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin Caledonian Record FORT LAUDERDALE, FL / ACCESS Newswire / May 21, 2026 / Sunshine Biopharma Inc. (NASDAQ: SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the…...
Amneal Launches Generic Bimatoprost Ophthalmic Solution 0. 01%
1+ mon, 2+ week ago (69+ words) Voice of Healthcare Voice of Healthcare acts as an industry connect platform that sources ideas, synergizes stakeholders, and solves bottlenecks to advance healthcare relentlessly. Host or sponsor events that place your brand at the forefront of healthcare impact. Engage a…...
Amneal: A Robust Drug Portfolio Worth Watching, Driving Further Upside Potential (AMRX)
1+ mon, 5+ day ago (212+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to…...
Two Health Care Products Developed At Amneal Pharmaceuticals Launch On The American Market
1+ mon, 6+ hour ago (346+ words) Two Health Care Products Developed At Amneal Pharmaceuticals In Cashel Have Been Launched On The American Market'Tipp Mid West Radio Two health care products developed at Amneal Pharmaceuticals in Cashel have been launched on the US Market. The US Food…...
Amera Mex International Reports First Quarter for The Period Ended March 31, 2026 " Trading View News
1+ week, 5+ day ago (144+ words) Stable revenue with an 80 percent increase in gross profit Amera Mex Reports First Quarter 2026 Results and Market Outlook First Quarter Financial Highlights, Ended March 31, 2026, Vs First Quarter Ended March 31, 2025 On the balance sheet, current assets decreased by $1. 8 million to approximately…...
Amneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Assenagon Asset Management S. A.
2+ mon, 2+ day ago (146+ words) Shares of AMRX opened at $12. 07 on Wednesday. Amneal Pharmaceuticals, Inc. has a 12 month low of $6. 68 and a 12 month high of $15. 42. The stock has a fifty day moving average price of $13. 66 and a 200 day moving average price of $12. 14. The company has…...